PRAE:XETRA:XETRA-Amundi Index Solutions - Amundi Prime Europe UCITS ETF DR (C) (EUR)

ETF | Others |

Last Closing

USD 27.87

Change

-0.06 (-0.21)%

Market Cap

USD 0.09B

Volume

1.91K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.30 (+0.57%)

USD 511.43B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.07 (+0.42%)

USD 191.96B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.16 (+0.55%)

USD 177.46B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.13 (+0.48%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

N/A

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.26 (+0.56%)

USD 100.46B
8R80:XETRA Amundi Index Solutions - Amund..

+0.46 (+0.32%)

USD 98.85B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.23 (+0.45%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.58 (-0.11%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.20 (+0.88%)

USD 79.79B

ETFs Containing PRAE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.79% 65% D 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.79% 64% D 64% D
Trailing 12 Months  
Capital Gain 15.74% 63% D 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.74% 62% D 64% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.13% 71% C- 69% C-
Dividend Return 9.13% 71% C- 67% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.18% 50% F 60% D-
Risk Adjusted Return 74.97% 86% B+ 87% B+
Market Capitalization 0.09B 31% F 28% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.